Investigation of Hair Diseases Accompanying Bitemporal Alopecia: An Observational Cross-Sectional Study

    January 2026 in “ Journal of Clinical Practice and Research ”
    Dilek Menteşoğlu, Gizem Soran, Neslinur Sali, Afra Akçam, Şeyma Nur Erol, Selda Pelin Kartal
    TLDR Bitemporal alopecia often occurs with other hair conditions and can help predict and monitor these issues.
    This observational cross-sectional study investigated hair diseases accompanying bitemporal alopecia in 86 patients, with a mean age of 36.2 years. The study found that bitemporal alopecia often coexists with other hair conditions, such as androgenetic alopecia (66.3%), seborrheic dermatitis (44.2%), and telogen effluvium (33.7%). The severity of bitemporal alopecia was categorized as mild (25.6%), moderate (46.5%), and severe (27.9%). The study suggests that bitemporal alopecia could be a predictive indicator for diagnosing and monitoring associated hair diseases.
    Discuss this study in the Community →

    Related Community Posts Join

    4 / 4 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      by nkrata in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.
      Should i be worried dut 6 months

      community Should i be worried dut 6 months

      by Metro_V in General  122 upvotes 2 months ago
      The user has been using finasteride and minoxidil, then switched to dutasteride and minoxidil for six months without significant results, noticing thinning after increasing creatine dosage. They plan to consult a dermatologist to explore potential causes beyond androgenetic alopecia.

      community PP405 2a study was a safety study. Some rational explaining.

      in Research/Science  22 upvotes 6 months ago
      The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.

    Similar Research

    5 / 536 results